ArticleMolecular therapy : the journal of the American Society of Gene Therapy2020

TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.

Kevin Lynch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.